Skip to content

Universe Pharmaceuticals INC

UPC· Nasdaqxbrl foundCIK 1809616

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -2.80%
Market cap
—
no share count on file
Filings
119
$17.86B
FY 2025−22.4% FY25 yoy
-$3.67B
FY 2025N/M FY25 yoy
-$2.92B
FY 2025N/M FY25 yoy
-$5.32B
FY 2025derivedN/M FY25 yoy
-$8.06
FY 2025N/M FY25 yoy
$33.59B
FY 2025+13.9% FY25 yoy

Price

$1.5756.65%$2.05past year
Nov 12, 2026 · IEX last sale
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$17.86BFY 2025
$32.31B0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-09-30$17,858,732,000reported
FY 20242024-09-30$23,024,458,000 revisedreported
FY 20232023-09-30$32,308,735,000 revisedreported
FY 20222022-09-30$40,143,151reported
FY 20212021-09-30$47,982,031reported
FY 20202020-09-30$30,703,960reported
FY 20192019-09-30$33,229,316reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2019$16.01M—$16.01M———122.0%

Segments

Products
Revenue by Products, FY2023 to FY2025FY2023Revenue from sales of self-manufactured TCMD products · FY2023 · $18.57BRevenue from sales of third-party products · FY2023 · $13.74BFY2024Revenue from sales of self-manufactured TCMD products · FY2024 · $14.03BRevenue from sales of third-party products · FY2024 · $9.00BFY2025Revenue from sales of self-manufactured TCMD products · FY2025 · $13.26BRevenue from sales of third-party products · FY2025 · $4.60B
LineFY2025ShareChange
Revenue from sales of self-manufactured TCMD products$13.26B74%−5.5%
Revenue from sales of third-party products$4.60B26%−48.9%
Total$17.86B

From the 20-F filed Jan 29, 2026UPC

Pharmaceutical preparations

Universe Pharmaceuticals INC is the 9th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Universe Pharmaceuticals INC · CIK 1809616 · Engraved from SEC EDGAR